40 individuals (49.4%) had a CEA level of > 192 ng/mL, of whom 39 (97.5%) were diagnosed as having MCN and IPMN, and one (2.5%) was diagnosed as having SCN based on EUS results. This evidence concerns the gene CEACAM5 and pancreatic intraductal papillary-mucinous neoplasm.